What are sulfonamides and how do they affect the body. How common are sulfa allergies and what are the main symptoms. What is the difference between sulfa and sulfite allergies. How are sulfa allergies treated and prevented.

Understanding Sulfonamides and Sulfa Allergies

Sulfonamides, commonly known as sulfa drugs, are a group of medications that contain sulfa compounds. These drugs are widely used to treat various conditions, but they can cause allergic reactions in some individuals. A sulfa allergy occurs when the immune system overreacts to these medications, leading to a range of symptoms and potential complications.

The prevalence of sulfa allergies is relatively low. According to research, approximately 3% of people prescribed sulfa antibiotics experience adverse reactions. However, only about 3% of these adverse reactions are true allergic responses. This means that the actual number of individuals experiencing allergic reactions to sulfa drugs is extremely small.

Key Facts About Sulfa Allergies

• Sulfa allergies are different from sulfite allergies
• Symptoms can range from mild to severe
• True allergic reactions are rare
• Proper diagnosis and management are essential

Sulfa vs. Sulfite Allergies: Understanding the Difference

It’s crucial to differentiate between sulfa allergies and sulfite allergies, as they are often confused due to the similarity in their names. Sulfa allergies are reactions to sulfonamide medications, while sulfite allergies involve sensitivity to sulfites, which are preservatives found in some foods and beverages.

Can individuals with sulfa allergies consume sulfite-containing products? Generally, having a sulfa allergy does not mean you’ll be allergic to sulfites, and vice versa. However, it’s always best to consult with a healthcare professional if you have concerns about either type of allergy.

Recognizing Symptoms of Sulfa Allergies

Identifying the symptoms of a sulfa allergy is crucial for prompt treatment and prevention of complications. The manifestations of a sulfa allergy can vary from person to person and may range from mild to severe.

Common Symptoms of Sulfa Allergies

• Skin rash or hives
• Itchy eyes and skin
• Congestion
• Swelling of the mouth and throat

How quickly do sulfa allergy symptoms appear? Symptoms can develop within hours or days after taking a sulfa-containing medication. In some cases, reactions may occur more rapidly, especially in individuals who have been previously sensitized to sulfa drugs.

Severe Complications of Sulfa Allergies

While most sulfa allergic reactions are mild, some individuals may experience severe complications that require immediate medical attention. Two of the most serious complications are anaphylaxis and Stevens-Johnson syndrome.

Anaphylaxis: A Life-Threatening Emergency

Anaphylaxis is a severe, potentially life-threatening allergic reaction that can occur in response to sulfa drugs. It typically develops rapidly, often within minutes of exposure to the allergen.

What are the warning signs of anaphylaxis? Key symptoms include:

• Itchy red rash with hives or welts
• Swelling in the throat or other body areas
• Wheezing, coughing, or difficulty breathing
• Chest tightness
• Difficulty swallowing
• Gastrointestinal symptoms such as vomiting and diarrhea
• Changes in skin color (pale or red)

Who is at higher risk for anaphylaxis? Individuals with a history of other allergies, asthma, or a family history of anaphylaxis are at increased risk for this severe reaction.

Stevens-Johnson Syndrome: A Rare but Serious Complication

Stevens-Johnson syndrome (SJS) is a rare but severe skin reaction that can be triggered by sulfa drugs. This condition affects the skin and mucous membranes, causing painful blistering and potentially life-threatening complications.

What are the characteristic symptoms of Stevens-Johnson syndrome? Key indicators include:

• Abnormal skin blistering
• Reddening of the skin
• Fatigue
• Diarrhea
• Nausea and vomiting
• Fever

Is Stevens-Johnson syndrome more common in certain populations? Yes, SJS is more frequently observed in men than in women. Additionally, some individuals may have a genetic predisposition to developing this condition.

Common Medications Containing Sulfa

Sulfa is present in various medications, including both antibiotics and non-antibiotic drugs. Understanding which medications contain sulfa is crucial for individuals with known sulfa allergies to avoid potential reactions.

Sulfa-Containing Antibiotics

Antibiotic medications containing sulfa are more likely to trigger allergic reactions compared to non-antibiotic sulfa drugs. Some common sulfa antibiotics include:

• Sulfamethoxazole-trimethoprim (Bactrim, Septra)
• Erythromycin-sulfisoxazole (Eryzole, Pediazole)

Non-Antibiotic Sulfa Medications

Several non-antibiotic medications also contain sulfa compounds. These include:

• Diabetes medications (e.g., glyburide)
• Sulfasalazine (used for rheumatoid arthritis, Crohn’s disease, and ulcerative colitis)
• Dapsone (used for dermatitis and certain types of pneumonia)
• Sumatriptan (used for migraines)
• Some anti-inflammatory drugs (e.g., celecoxib)
• Certain diuretics (e.g., hydrochlorothiazide, furosemide)

Are there sulfa-free alternatives for these medications? In many cases, yes. Healthcare providers can often prescribe alternative medications that do not contain sulfa for individuals with known allergies.

Diagnosis and Treatment of Sulfa Allergies

Diagnosing and treating sulfa allergies requires careful medical evaluation and management. While there are no specific diagnostic tests for sulfa allergies, healthcare providers rely on patient history and observed symptoms to make a diagnosis.

Treatment Approaches for Sulfa Allergies

The primary goal of treatment is to alleviate symptoms and prevent further allergic reactions. Common treatment strategies include:

• Antihistamines to relieve hives, rash, and itching
• Corticosteroids to reduce inflammation
• Bronchodilators for respiratory symptoms

In cases where a sulfa medication is necessary and no alternatives are available, healthcare providers may consider a desensitization procedure. This involves gradually introducing the medication at low doses and carefully monitoring for allergic reactions as the dosage is increased.

Emergency Treatment for Severe Reactions

Both anaphylaxis and Stevens-Johnson syndrome require immediate medical attention. Anaphylaxis is typically treated with epinephrine, while Stevens-Johnson syndrome often necessitates intensive care unit admission.

How is Stevens-Johnson syndrome managed? Treatment may include:

• Corticosteroids to control inflammation
• Antibiotics to prevent or treat skin infections
• Intravenous immunoglobulins to halt disease progression

Preventing Sulfa Allergy Reactions

Preventing allergic reactions to sulfa drugs is crucial for individuals with known sensitivities. While there are no specific tests to predict sulfa allergies, there are several strategies to minimize the risk of reactions.

Key Prevention Strategies

1. Inform all healthcare providers, including dentists and pharmacists, about your sulfa allergy
2. Wear a medical alert bracelet or necklace indicating your allergy
3. Always read medication labels carefully
4. Ask your healthcare provider about safe alternatives to sulfa-containing drugs
5. Be cautious with new medications and monitor for any allergic symptoms

Can sulfa allergies be outgrown? While some allergies can be outgrown over time, sulfa allergies typically persist throughout life. It’s essential to remain vigilant and avoid sulfa-containing medications unless under close medical supervision.

Living with a Sulfa Allergy: Practical Considerations

Managing a sulfa allergy requires ongoing awareness and proactive measures to ensure safety and well-being. Understanding how to navigate daily life with this allergy is crucial for affected individuals.

Communicating Your Allergy

Effective communication about your sulfa allergy is vital in various healthcare settings. How can you ensure your allergy is properly documented and considered?

• Maintain an up-to-date list of all your allergies and medications
• Discuss your allergy with new healthcare providers during initial consultations
• Verify that your allergy is noted in your medical records at each visit
• Ask questions about prescribed medications and their ingredients

Navigating Emergency Situations

In emergency situations, it’s crucial that medical personnel are aware of your sulfa allergy. What steps can you take to prepare for unexpected medical emergencies?

• Carry a medical alert card or wear medical alert jewelry
• Keep emergency contact information readily accessible
• Educate family members and close friends about your allergy and emergency procedures

Is it possible to receive sulfa medications in emergencies despite having an allergy? In some critical situations, healthcare providers may need to weigh the risks and benefits of administering sulfa drugs. They will carefully monitor for any adverse reactions and be prepared to manage them if they occur.

Advances in Sulfa Allergy Research and Management

The field of allergy research is continuously evolving, with ongoing efforts to improve diagnosis, treatment, and management of sulfa allergies. Understanding recent developments and future directions can provide valuable insights for individuals affected by this condition.

Current Research Trends

What are some of the key areas of focus in sulfa allergy research? Current studies are exploring:

• Genetic factors that may predispose individuals to sulfa allergies
• More precise diagnostic tools to identify true sulfa allergies
• Novel treatment approaches to manage severe allergic reactions
• Development of sulfa-free alternatives for common medications

Future Prospects in Sulfa Allergy Management

How might sulfa allergy management evolve in the coming years? Potential advancements may include:

• Personalized medicine approaches based on genetic profiles
• Improved desensitization protocols for individuals who require sulfa medications
• Enhanced predictive models to assess the risk of allergic reactions
• Development of targeted therapies to prevent or mitigate allergic responses

As research progresses, individuals with sulfa allergies may benefit from more tailored and effective management strategies, potentially improving their quality of life and expanding their treatment options.

Sulfa Allergies in Special Populations

While sulfa allergies can affect anyone, certain populations may require special considerations in terms of diagnosis, treatment, and management. Understanding these unique challenges is essential for comprehensive care.

Sulfa Allergies in Pregnancy

Managing sulfa allergies during pregnancy presents unique challenges. How do healthcare providers balance the need for treatment with potential risks to the fetus?

• Careful assessment of the risks and benefits of sulfa medications
• Exploration of alternative treatments when possible
• Close monitoring of both mother and fetus if sulfa drugs are necessary
• Consideration of the potential impact on fetal development

Pediatric Sulfa Allergies

Diagnosing and managing sulfa allergies in children requires special attention. What unique factors come into play when dealing with pediatric patients?

• Age-appropriate communication about symptoms and medication use
• Careful dosing considerations based on weight and age
• Education of parents and caregivers about recognizing allergic reactions
• Long-term monitoring for potential changes in allergy status as the child grows

Can children outgrow sulfa allergies? While some childhood allergies may resolve over time, sulfa allergies often persist into adulthood. Regular reassessment by an allergist can help monitor any changes in allergy status.

Elderly Patients and Sulfa Allergies

Older adults may face additional challenges when it comes to managing sulfa allergies. What specific considerations are important for this population?

• Increased risk of drug interactions due to multiple medications
• Potential for altered drug metabolism affecting allergic responses
• Importance of clear communication with multiple healthcare providers
• Consideration of cognitive factors in medication management and symptom reporting

By addressing the unique needs of these special populations, healthcare providers can ensure more comprehensive and effective management of sulfa allergies across all age groups and life stages.

Drug List, Symptoms, Treatment, and More

Like other drug allergies, a sulfa allergy may be accompanied with symptoms like hives, itchy skin, or swelling in the mouth or throat. It differs from a sulfite allergy.

A sulfa allergy is when you have an allergic reaction to drugs that contain sulfa. About 3 percent of people prescribed sulfa antibiotics will have an adverse reaction to them, according to one review. However, it’s estimated that of those who have an adverse reaction, only 3 percent are true allergic reactions. That means that number of people who experience an allergic reaction to sulfa is extremely low.

Sulfa vs. sulfite allergy

Sulfa allergies and sulfite allergies aren’t the same thing. Sulfites occur naturally, or are used as a preservative agent in some foods and drinks. Sulfa medications and sulfites found in food and drink aren’t related to each other. The similarity between their names can cause some confusion. Read more about the difference between sulfa allergies and sulfite allergies.

Symptoms of sulfa allergy are similar to those of other drug allergies. Symptoms may include:

• skin rash or hives
• itchy eyes
• itchy skin
• congestion
• swelling of the mouth
• swelling of the throat

Sulfa allergy can result in serious complications, including anaphylaxis and Stevens-Johnson syndrome.

Anaphylaxis

Anaphylaxis is a severe and potentially life-threatening type of allergic reaction. You’re at an increased risk for this type of reaction if you have:

• other allergies
• asthma
• a family history of anaphylaxis

Symptoms of anaphylaxis typically develop within 5 to 30 minutes of exposure to an allergen. These symptoms include:

• an itchy red rash that includes hives or welts
• swelling in the throat or possibly other areas of the body
• wheezing, coughing, or difficulty breathing
• tightness of the chest
• difficulty swallowing
• vomiting
• diarrhea
• cramping of the stomach
• pale or red color of the face or body

Stevens-Johnson syndrome

Stevens-Johnson syndrome is a rarer complication of sulfa allergy. This condition consists of painful and blistered lesions on the skin and mucus membranes, including the:

• mouth
• throat
• eyes
• genital region

Stevens-Johnson syndrome is more common in men than women. Some people also have a genetic predisposition for the condition.

Symptoms of Stevens-Johnson syndrome include:

• abnormal skin blistering
• reddening of the skin
• fatigue
• diarrhea
• nausea and vomiting
• fever

Sulfa is found in a variety of medications, including antibiotics and nonantibiotic drugs. An allergic reaction is more likely to occur from exposure to sulfa-containing antibiotics.

Sulfa-containing drugs include:

• sulfonamide antibiotics, including sulfamethoxazole-trimethoprim (Bactrim, Septra) and erythromycin-sulfisoxazole (Eryzole, Pediazole)
• some diabetes medications, such as glyburide (Diabeta, Glynase PresTabs)
• the drug sulfasalazine (Azulfidine), used in the treatment of rheumatoid arthritis, Crohn’s disease, and ulcerative colitis
• the drug dapsone, used to treat dermatitis and some types of pneumonia
• the drug sumatriptan (Imitrex), used to treat migraines
• some anti-inflammatory drugs, such as celecoxib (Celebrex)
• some diuretics, such as hydrochlorothiazide (Microzide) and furosemide (Lasix)

Are sulfas found in foods?

Having an allergy to sulfa drugs is different from having an allergy to food or drinks that contain sulfites. Unless you’ve had a reaction to sulfites, consuming food or drink that contains sulfites is OK. Conversely, if you’ve had an allergic reaction to sulfites, it doesn’t mean that you’ll also be allergic to sulfa drugs.

If you have an allergic reaction to sulfa drugs, treatment will be centered on relieving your symptoms. Your doctor may prescribe antihistamines or corticosteroids to relieve hives, rash, and itching. A bronchodilator may be prescribed if you have respiratory symptoms.

Your doctor may recommend a desensitization procedure if you need medication and there isn’t a sulfa-free alternative. Desensitization involves slowly introducing the medication at low doses until an effective dose is reached and tolerated. You’ll be monitored for allergic reactions as the medication doses are increased.

Both anaphylaxis and Stevens-Johnson syndrome require immediate medical attention. If you’re having an anaphylactic reaction, epinephrine will usually be given.

If you develop Stevens-Johnson syndrome, you’ll likely be admitted to an intensive care unit. Treatment for Stevens-Johnson syndrome includes:

• corticosteroids to control inflammation
• antibiotics to prevent or control skin infections
• intravenous (IV) immunoglobulins to halt the progress of the disease

There are no diagnostic tests for sulfa allergy. However, some tips for prevention of a further allergic reaction to sulfa drugs include:

• Make sure all healthcare providers, including your dentist and pharmacy, are aware of your drug allergies. This will help them be aware of which medications should be avoided.
• If you have previously had a severe or anaphylactic reaction to sulfa drugs, carry an emergency epinephrine syringe (EpiPen).
• Carry a medical alert card with you or wear a medical alert bracelet that alerts care staff of your allergy. This will ensure proper treatment if you have a reaction and are unable to verbally alert medical providers of your allergy.

Having a sulfa allergy means you have an allergic reaction to medications containing sulfa. While there are many medications that contain sulfa, allergic reactions to sulfa antibiotics are most common. Sulfa allergy and allergy to sulfites found in food or drink aren’t the same thing.

Symptoms of an allergic reaction to sulfa drugs include rash or hives, itchy skin or eyes, and swelling. Complications of sulfa allergy include anaphylaxis and Steven-Johnson syndrome. Both of these are considered medical emergencies.

Always make sure that your healthcare providers are aware of your sulfa allergy so medications containing sulfa can be avoided. Let your healthcare provider know right away if you suspect a sulfa allergy.

Page not found | Minnesota Department of Agriculture

• Business Dev, Loans, Grants
  • 1. Business & Marketing
       1. Corporate Farm Information
       2. Food Business Development
       3. Exporting & International Trade
       4. Economic Analysis & Market Research
       5. Local & Regional Markets
    2. Resources for Farmers
       1. Beginning Farmer Tax Credit
       2. Emerging Farmers
       3. Farm Advocates
       4. Farmer Stress
       5. Farm, Property, Real Estate Listing (MN FarmLink)
    3. Disaster & Cleanup Assistance
       1. Agriculture Chemical Response & Reimbursement Account
       2. Elk Damage Compensation
       3. Wolf Depredation
    4. Animals & Livestock
       1. Livestock Dealer Licensing
       2. Livestock Resources
    5. Loans
       1. VIEW ALL Loans & Funding
       2. Disaster Recovery Loan
       3. Aggie Bond Loan
       4. Agricultural Best Management Practices (AgBMP) Loan
       5. Beginning Farmer Loan
       6. Farm Opportunity Loan
       7. Rural Finance Authority
       8. Loan Comparison Chart
    6. Grants
       1. VIEW ALL Grants & Funding
       2. Local Food Purchase Assistance
       3. Down Payment Assistance Grant
       4. Agricultural Growth, Research & Innovation (AGRI) Program
       5. Value-Added (AGRI)
       6. Specialty Crop
       7. Livestock Investment (AGRI)
    7. More Business Development, Loans, Grants Topics
• Environment, Sustainability
  • 1. Conservation
       1. Minnesota Ag Water Quality Certification Program
       2. Best Management Practices
    2. Organic Agriculture
       1. Organic Agriculture
       2. Minnesota Organic Conference
    3. Renewable Energy
       1. Governor’s Council on Biofuels
       2. Biodiesel
       3. Ethanol
       4. Manure Digesters
       5. AGRI Bioincentive Program
       6. AGRI Biofuels Infrastructure Grant
    4. Water Protection
       1. Clean Water Fund Activities
       2. Minnesota Ag Water Quality Certification Program
       3. Water Monitoring Programs
    5. Farmland Protection
       1. Farmland Protection
    6. Climate Change
       1. Agriculture in a Changing Climate
    7. More Environment, Sustainability Topics
• Pesticide, Fertilizer
  • 1. Pesticides
       1. VIEW ALL Specific Pesticides
       2. Pesticide Overview
       3. Apply, Register, Store, Sell
       4. Pesticide Use & Sales Data
       5. Monitoring Pesticides in Water
       6. Regulation, Inspection & Enforcement
       7. Dicamba
       8. Integrated Pest Management
    2. Fertilizers
       1. Fertilizer Overview
       2. Apply, Register, Store, Sell
       3. Fertilizer Use & Sales Data
       4. Monitoring Nitrate in Water
       5. Ag Lime
       6. Anhydrous Ammonia Program
       7. Certified Testing Laboratories (soil & manure)
       8. Fertilizer Practices
    3. Best Management Practices
       1. Nitrogen Fertilizer BMPs
       2. Pest Control without Pesticide BMPs
       3. Pesticide BMPs
       4. Pollinator Habitat BMPs
       5. Turfgrass BMPs
    4. Safety & Cleanup
       1. Spills & Cleanup
       2. Waste Pesticide Disposal
       3. Pesticide Container Recycling
       4. Health & Safety
    5. File a Misuse Complaint
       1. Pesticide & Fertilizer Complaints
    7. Licensing & Registration
       1. Search Licenses
       2. License Lookup
       3. Fertilizer Tonnage Reporting & Inspection Fees
       4. Pesticide Dealer Licensing & Sales Reporting
    8. Clean Water Fund Activities
       1. Clean Water Fund Activities
    9. More Pesticide & Fertilizer Topics
• Food, Feed
  • 1. Feed & Pet Food Business Info
       1. Certificate of Free Sale
       2. CGMP Certificate Request
    2. Food & Feed Safety
       1. VIEW ALL Food Safety
       2. Secure Milk Supply Program
       3. Food Ingredients/Allergens
       4. Food Safety Modernization Act (FSMA)
       5. Drug Residue Prevention
    3. Resources for New Food Businesses
       1. How to Start a Food Business
       2. Licensing Wizard
       3. Licensing Liaison Request
       4. Food Licenses & Regulations
       5. Meat & Poultry Processing
       6. Wild Game Processing
    4. Selling Food & Feed
       1. Meat, Poultry & Eggs
       2. Dairy & Milk
       3. Labeling Requirements
       4. Minnesota Grown
       5. Cottage Food
       6. Venison Donation
       7. Hemp in Food
    5. Recalls & Complaints
       1. Report a Complaint
       2. Recent Recall Notifications
    6. Food & Feed Inspection Programs
       1. Retail Food Program
       2. Retail Food Plan Review
       3. Manufactured Food Program
       4. Produce Safety Program
       5. Commercial Feed Program
       6. Pet Food Program
    7. More Food, Feed Topics
• Plants, Insects
  • 1. Insect Pests & Diseases
       1. VIEW ALL Insect Pests & Diseases
       2. Report a Plant, Pest or Disease
       3. Emerald Ash Borer
       4. Spongy Moth
       5. Brown Marmorated Stink Bug
       6. Japanese Beetle
       7. Swede Midge
       8. Velvet Longhorned Beetle
       9. Bacterial Wilt and Canker of Tomato
       10. Potato Cyst Nematode
       11. Red Star Rust
    2. Pest Management
       1. Pest Regulations
       2. Biological Control of Emerald Ash Borer
       3. Spongy Moth Treatments
       4. Pest Surveys
       5. Research
    3. Plants
       1. Industrial Hemp
       2. Nursery
       3. Cold Hardiness List
       4. Noxious & Invasive Weeds
       5. Seed
       6. Grain
       7. Palmer Amaranth
       8. Noxious Weed Grant
    4. Beneficial Insects
       1. Pollinators
    5. Licensing
       1. VIEW ALL Licensing
       2. Grain Buy & Store
       3. Plants, Trees & Seed
       4. Firewood
    6. More PLANTS, INSECTS topics
• Licensing & Inspections
  • 3. Learn, Apply, Renew or Train
       1. VIEW ALL Licenses
       2. Crops
       3. Dairy, Milk
       4. Feed, Pet Food
       5. Fertilizers, Pesticides & Chemicals
       6. Food – Cottage, Retail, Wholesale
       7. Livestock
       8. Meat, Poultry, Eggs
       9. Plants, Trees & Seed
       10. Produce, Fruits, Vegetables, Grain
       11. Other
    4. View all Licensing & Inspections

The page you requested does not exist. For your convenience, a search was performed using the query sites default files inline files 31%20sulfonamide%20use%20on%20the%20dairy%20farm%209 2 20%20web%20current pdf.

Your search yielded no results.

• Check if your spelling is correct.
• Remove quotes around phrases to search for each word individually. bike shed will often show more results than “bike shed”.
• Consider loosening your query with OR. bike OR shed will often show more results than bike shed.

Sulfanilamide – description of the substance, pharmacology, use, contraindications, formula

Contents

• Structural formula

• Russian name

• English name

• Latin name

• chemical name

• Gross formula

• Pharmacological group of the substance Sulfanilamide

• Nosological classification

• CAS code

• pharmachologic effect

• Characteristic

• Pharmacology

• Application of the substance Sulfanilamide

• Contraindications

• Application restrictions

• Use during pregnancy and lactation

• Side effects of the substance Sulfanilamide

• Interaction

• Dosage and administration

• Precautionary measures

• Trade names with the active substance Sulfanilamide

Structural formula

Russian name

Sulfanilamide

English name

Sulfanilamide

Latin name

genus Sulfanilamidi)

Chemical name

4-Aminobenzenesulfonamide

General formula

C ₆ H ₈ N ₂ O ₂ S

Pharmacological group of the substance Sulfanilamide

Sulfonamides

Nosological classification

ICD-10 code list

CAS code

63-74-1

Pharmacological action

Pharmacological action 90 097-

antimicrobial .

Description

Refers to short-acting sulfa drugs. Sulfanilamide is a white, odorless, crystalline powder with a slightly bitter taste and a sweet aftertaste. Easily soluble in boiling water (1:2), difficult – in ethanol (1:37), soluble in solutions of hydrochloric acid, caustic alkalis, acetone (1:5), glycerin, propylene glycol; practically insoluble in ether, chloroform, benzene, petroleum ether. Molecular weight – 172.21.

Also used as sodium methane sulfate (Streptocide soluble) – white crystalline powder; soluble in water, practically insoluble in organic solvents.

Pharmacology

The mechanism of antimicrobial action of sulfanilamide is associated with the antagonism of PABA, with which it has a chemical similarity. Sulfanilamide is captured by the microbial cell, prevents the incorporation of PABA into dihydrofolic acid and, in addition, competitively inhibits the bacterial enzyme dihydropteroate synthetase (the enzyme responsible for the incorporation of PABA into dihydrofolic acid), as a result, the synthesis of dihydrofolic acid is disrupted, and the formation of metabolically active tetrahydrofolic acid from it, which is necessary for the formation of purines and pyrimidines, stops the growth and development of microorganisms (bacteriostatic effect).

Active against gram-positive and gram-negative cocci (including streptococci, pneumococci, meningococci, gonococci), Escherichia coli, Shigella spp. Chlamydia spp. , Actinomyces israelii, Toxoplasma gondii.

When applied topically, promotes rapid wound healing.

When taken orally, it is rapidly absorbed from the gastrointestinal tract. max”>C _max in the blood is created after 1–2 hours and decreases by 50%, usually in less than 8 hours. It passes through the histohematic, including the BBB, placental barriers. It is distributed in tissues, after 4 hours it is found in the cerebrospinal fluid. It is acetylated in the liver with loss of antibacterial properties. It is excreted mainly (90-95%) by the kidneys.

There is no information on carcinogenicity, mutagenicity and effects on fertility with long-term use in animals and humans.

Sulfanilamide used to be used orally to treat angina, erysipelas, cystitis, pyelitis, enterocolitis, prevention and treatment of wound infection. Sulfanilamide (Streptocid soluble) has been used in the past as 5% aqueous solutions for intravenous administration, which were prepared ex tempore ; currently used only in the form of liniment for external use.

Application of Sulfanilamide Sulfanilamide Sulfanilamide

local : tonsillitis, purulent-inflammatory lesions of the skin, infected wounds of various etiologies (including ulcers, cracks), furunculus, carbuncle, pyoderma, erysipelas, vulgar acne, impetigo, burns (I and II degrees).

Contraindications

Hypersensitivity (including to other sulfonamides and sulfonamides), diseases of the hematopoietic system, anemia, renal / hepatic insufficiency, congenital deficiency of glucose-6-phosphate dehydrogenase, azotemia, porphyria.

Restrictions for use

Pregnancy, lactation.

Use in pregnancy and lactation

Systemically absorbed sulfanilamide can rapidly cross the placenta and be detected in the blood of the fetus (the concentration in the blood of the fetus is 50-90% of that in the mother’s blood), as well as cause toxic effects. The safety of sulfanilamide during pregnancy has not been established. It is not known whether sulfonamide can cause fetal harm when taken by pregnant women. In experimental studies in rats and mice treated during pregnancy with certain short, intermediate and long-acting sulfonamides (including sulfanilamide) orally at high doses (7-25 times the therapeutic oral dose for humans), a significant increase in the incidence of cleft palate and other fetal bone malformations.

Passes into breast milk, may cause kernicterus in neonates.

Adverse effects of the substance Sulfanilamide

Allergic reactions; with prolonged local use in large quantities – a systemic effect: headache, dizziness, paresthesia, tachycardia, nausea, vomiting, dyspepsia, leukopenia, agranulocytosis, crystalluria, cyanosis.

Interaction

Myelotoxic drugs increase hematotoxicity.

Dosage and administration

Local . With superficial infectious diseases of the skin and mucous membranes of the nasal cavity and ear, with burns, ulcers, etc. used in the form of 10% ointment, 5% liniment or powder. Liniment or ointment is applied directly to the affected surface or smeared on a gauze; dressings are made in 1-2 days. For deep wounds, sulfanilamide is introduced into the wound cavity in the form of a carefully ground sterilized powder (5–10–15 g), while sulfanilamide or other antibacterial drugs are administered orally. In a mixture with sulfathiazole, benzylpenicillin and ephedrine, it is sometimes used topically (for acute rhinitis) in powder form (by blowing or drawing it into the nose when inhaling).

Precautions

Periodic peripheral blood testing is necessary for long-term use.

Trade names with active ingredient Sulfanilamide

Reset filters

Lek. form
All lek. forms liniment ointment for local and external use ointment for external use powder for external use substance substance-powder

Dosage
All dosages 10 g 10% 15 g 2 g 25 g 5 g 5% No dosage

Manufacturer
All manufacturers Avexima Siberia LLC Aromasintez LLC BioPharmCombinat LLC Biosintez OJSC Biosintez PJSC Zelenaya Dubrava CJSC Ivanovskaya Pharmaceutical Factory Irbit Chemical and Pharmaceutical Plant OJSC Lekar Lumi LLC [St. Petersburg] Meligen FP CJSC Moscow Pharmaceutical Factory NIZHFARM OAO Ozone LLC Samaramedprom Tver Pharmaceutical Factory OJSC Technopark -Center LLC Tula Pharmaceutical Factory LLC Tyumen Chemical-Pharmaceutical Plant Usolye-Sibirsky CPP JSC Usolye-Sibirsky CPP JSC Flora of the Caucasus JSC Flora of the Caucasus JSC Hubei Maxpharm Industries Co. Zhejiang Kemsen Pharm Co., Ltd. Empils-Foch JSC YuzhFarm LLC Yaroslavl Pharmaceutical Factory (ZAO YAFF)

Diabetes mellitus and coronary heart disease: the mystery of sulfonamides | Aleksandrov

1. American Diabetes Association; National Heart, Lung and Blood Institute; Juvenile Diabetes Foundation International; National Institute of Diabetes and Digestive and Kidney Disease; American Heart Association.//Circulation 1999; 100: 1132-1133

2. Aschcroft FM, Gribble FM.//Diabetologia 1 999; 42: 903-91 9.

3. Auchampach JA, maruyama M, Cavero I, Gross GJ. //Circulation 1992; 86:31 1-319.

4. Balkou B, Shipley M, Jarrett RJ et al. //Diabetes Care 1998; 21; 360-7.

5. Barrett Connor EM.//Diabetes Care 1997;20:1 620-3.

6. Baumbach A, Braun U, Doring G, Haase KK, Voelker W, Karsch Kr.//Cardiovascular Drugs Ther 1 995; 9:237-243.

7. Billman GE, Avendano CE, Halliwill JR, Burroughs JM.//Cardiovasc Pharmacol 1993; 21:197-204.

8. Boyd AE III, Aguilar-Bryan L, Nelson DA.//Am J Med 1 996.

9. Buoninconti R, Cagli V, Bossini A, DiVeroli C, DeCesaris R, Ranieri G, Rapelli A, Dessi ‘Fulgheri P.//Curr Ther Res 1 993; 53:638-647.

10. Butler WJ, Ostrander LD, Carman WJ, Lamphiear DE.//Am J Epidemol 1985; 121:541-7

11. Diabetes and Cardiovascular Disease. Time to act. International Diabetes Federation, 2001.

12. Engler RL, Yellon DM.//Circulation 1996; 94:2297-2301. 1 3. Escande D, Cavero I. // Trends Pharmacol Sci 1 992; 13:269-271.

13. Frampton J, Buckley MM, Fitton A.//Drugs 1 992;44: 625-655. 1 5. Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H. //BMJ 1 983; 287:867-70.

14. Galie N et al.,//Fm J Cardiol 1 990; 65:343-348.

15. Gross GJ.//Current Patients Ltd. ISSN 0961-4680, 191, KCM-B82KSM-B90.

16. Gross GJ, Auchampach JA.//Circ Res 1 992; 70:223-233. 1 9. Hariwer ADB, Clarke BF. //Br Med J 1976; 1:1 26-1 28.

17. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. //NEJM 1 998; 339:229-234.

18. Immamura Y, Tomoike H, Narishige T, Takahashi T, Kasuya H, Takeshita A.//Am J Physiol 1992; 263:h499-h504.

19. Kantor PF, Coetzee WA, Carmeliet EE, Dennis SC, Opie LH.//Circ Res 1990; 66:478-485.

20. Klein R.//Diabetes Care 1995; 18: 258-68

21. Klepzig H, Kober G, Matter C, Luus H, Schneider H, Boedeker KH, Kiowski W, Amann FW, Gruber D, Harris S, Burger W. //Eur Heart J 1999; 20:439-446.

22. Kondo T, Kubota I, Tachibana H, Yamaki M, Tomoike H.//Cardiovasc Res 1996; 31:683-7.

23. Kubota I, Yamaki M, Shibata T, Ikeno E, Hosoya Y, Tomoike H.//Circulation 1993; 88 (part I): 1845-1851.

24. Kuusisto J, Mykkanen L, Pyorala K, Laakso M.//Diabetes 1994;43: 960-7.

25. Lomuscio A, Vergani D, Marano L, Castagnone M, Fiorentini C.//Cor Art Dis 1994; 5:767-771.

26. Miettinen H, Lehto S, Salomaa W et al.//Diabetes Care 1998; 21:69-75.

27. Murakami M, et al. //Cardiovasc. Drug Ther. 1989; 3 (suppl. 2): 614-61 9.

28. Murry CE, Jennings RB, Reimer KA. //Circulation 1986; 74: 1 1 24-1 1 36.

29. Nichols CG, Lederer WJ. // Am J Physiol 1991; 261 :H 1 675HI 686.)

30. Noma A.//Nature 1983; 305:147-148.

31. O’Keefe JH, Blackstone EH, Sergeant P, McCallister BD. //Eur Heart J 1998; 19:1696-1703.

32. Oswold BU, Jonsby M, Grill V.//Scientific journal of the Union of doctors of Northern Europe 2000; 21:2560-2564.

33. Pan WH, Cedres Lb, Lui K et al. // Am J Epidemiol 1986; 123: 504-51 6.

34. Pitt B, Segal R, martines FA et al.//Lancet 1 997; 349: 747-75.

35. Purcell H, Fox K.//Br J Clin Pharmacol 1993; 47:1-5.